SUBSTITUTED PYRIDO[3,2-B]INDOYL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF AS ANTICANCER AGENTS

The present invention is directed to substituted pyrido[3,2-b ]indoyl compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions as anticancer agents. In particular, the present invention provides a compound of the formula (II). L...

Full description

Saved in:
Bibliographic Details
Main Authors DEGNAN, ANDREW P, DEBENEDETTO, MIKKEL V, GAVAI, ASHVINIKUMAR V, SCHMITZ, WILLIAM D, VACCARO, WAYNE, LEE, FRANCIS Y, HILL, MATTHEW D, HAN, WENING, MANDAL, SUNIL KUMAR, HUANG, HONG, QUESNELLE, CLAUDE A, GILL, PATRICE, NORRIS, DEREK J, STARRETT, JOHN E., JR, O'MALLEY, DANIEL, DELUCCA, GEORGE V, TOKARSKI, JOHN S, FANG, HAIQUAN
Format Patent
LanguageEnglish
French
Published 02.07.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is directed to substituted pyrido[3,2-b ]indoyl compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions as anticancer agents. In particular, the present invention provides a compound of the formula (II). La présente invention concerne des composés de pyrido[3,2-b]indoyl substitués, des compositions acceptables sur le plan pharmaceutique comprenant les composés de l'invention et des méthodes d'utilisation de ces compositions comme agents anticancéreux. Plus précisément, la présente invention concerne un composé de formule (II).
Bibliography:Application Number: CA20142934953